Home › Companies › CRISPR THERAPEUTICS AG
How asset managers voted at CRISPR THERAPEUTICS AG’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | CRISPR THERAPEUTICS AG | 33 | 485 |
| 2024-2025 | CRISPR THERAPEUTICS AG | 43 | 413 |
| 2023-2024 | CRISPR THERAPEUTICS AG | 37 | 414 |
Explore CRISPR THERAPEUTICS AG in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 13, 2026. This page is rebuilt weekly; built October 17, 2026.